ELEVATE: EarLy dEtection of cerVical cAncer in hard-to-reach populations of women through portable and point-of-care HPV TEsting
The ELEVATE consortium wants to empower women to screen for their cervical cancer risk in any setting while guaranteeing rapid and easy-to-understand results. To that end, the project will identify hard-to-reach women and design a screening strategy to access them. This strategy includes the development of a user-friendly, low-cost, portable self-sampling screening tool which will be able to detect 14 high-risk human papillomavirus (HPV) types and 2 proteomic cervical cancer biomarkers.
The simultaneous detection of HPV DNA with the proteomic marker will allow for more accurate detection of HPV infections associated with cervical cancer progression. Therefore more relevant patients can be detected and treated, thereby drastically reducing the cancer burden in these populations. An intervention during which the self-testing device will be piloted in hard-to-reach communities in Belgium, Portugal, Ecuador and Brazil will provide information about the acceptability and cost-effectiveness of the tool.
Website: https://elevate-hpv.com/
Funding agencies
This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 825747 Dit project heeft financiering ontvangen van het onderzoeks- en innovatieprogramma Horizon 2020 van de Europese Unie in het kader van subsidieovereenkomst nr. 825747.
Team
Olivier Degomme Heleen Vermandere Bo Verberckmoes Emmie Vanhooren Ines Keygnaert
Coordinator
Olivier Degomme, ICRH (Ghent University)
Partners
The ELEVATE project brings together a team of medical doctors, public health researchers, economists, biological engineers, and technology developers from: Universiteit Gent (Belgium), NOVA National School of Public Health (Portugal), Instituto National de Salud Publica/Consorcio de Investigación sobre VIH SIDA TB CISIDAT A.C. (Mexico), Universidad de Cuenca (Ecuador), Barretos Cancer Hospital, PIO XII Foundation (Brazil), Universitat Rovira i Virgili (Spain), Fraunhofer Institute for Microengineering and Microsystems IMM (Germany), Labman Automation Ltd (UK), and microLIQUID (Spain). Het ELEVATE-project brengt een team samen van artsen, volksgezondheidsonderzoekers, economen, biologische ingenieurs en technologieontwikkelaars van: Universiteit Gent (België), NOVA National School of Public Health (Portugal), Instituto National de Salud Publica/Consorcio de Investigación sobre VIH SIDA TB CISIDAT A.C. (Mexico), Universidad de Cuenca (Ecuador), Barretos Cancer Hospital, XI PIOI Foundation (Brazilië), Universitat Rovira i Virgili (Spanje), Fraunhofer Institute for Microengineering and Microengineering and Microengineering and Microsystems IMM (Duitsland), Labman Automation Ltd (UK) en microLIQUID (Spanje).
Period
January 01, 2019 - December 31, 2023
Project status
Project ongoing
Team members
Mr. Olivier Degomme
Ms. Ines Keygnaert
Ms. Heleen Vermandere
Countries
Belgium
Brazil
Ecuador
Germany
Mexico
Portugal
Spain
United Kingdom of Great Britain and Northern Ireland
Themes
Sexually transmitted infections (STIs)
Cervical cancer and HPV